Table of Content

1 Gene Therapy Products Market Overview
1.1 Product Overview and Scope of Gene Therapy Products
1.2 Gene Therapy Products Segment by Type
1.2.1 Global Gene Therapy Products Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Ex vivo
1.2.3 In Vivo
1.3 Gene Therapy Products Segment by Application
1.3.1 Global Gene Therapy Products Sales Comparison by Application: (2021-2027)
1.3.2 Cancer
1.3.3 Monogenic
1.3.4 Infectious disease
1.3.5 Cardiovascular disease
1.3.6 Other
1.4 Global Gene Therapy Products Market Size Estimates and Forecasts
1.4.1 Global Gene Therapy Products Revenue 2016-2027
1.4.2 Global Gene Therapy Products Sales 2016-2027
1.4.3 Gene Therapy Products Market Size by Region: 2016 Versus 2021 Versus 2027

2 Gene Therapy Products Market Competition by Manufacturers
2.1 Global Gene Therapy Products Sales Market Share by Manufacturers (2016-2021)
2.2 Global Gene Therapy Products Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Gene Therapy Products Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Gene Therapy Products Manufacturing Sites, Area Served, Product Type
2.5 Gene Therapy Products Market Competitive Situation and Trends
2.5.1 Gene Therapy Products Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Gene Therapy Products Players Market Share by Revenue
2.5.3 Global Gene Therapy Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Gene Therapy Products Retrospective Market Scenario by Region
3.1 Global Gene Therapy Products Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Gene Therapy Products Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Gene Therapy Products Market Facts & Figures by Country
3.3.1 North America Gene Therapy Products Sales by Country
3.3.2 North America Gene Therapy Products Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Gene Therapy Products Market Facts & Figures by Country
3.4.1 Europe Gene Therapy Products Sales by Country
3.4.2 Europe Gene Therapy Products Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Gene Therapy Products Market Facts & Figures by Region
3.5.1 Asia Pacific Gene Therapy Products Sales by Region
3.5.2 Asia Pacific Gene Therapy Products Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Gene Therapy Products Market Facts & Figures by Country
3.6.1 Latin America Gene Therapy Products Sales by Country
3.6.2 Latin America Gene Therapy Products Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Gene Therapy Products Market Facts & Figures by Country
3.7.1 Middle East and Africa Gene Therapy Products Sales by Country
3.7.2 Middle East and Africa Gene Therapy Products Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Gene Therapy Products Historic Market Analysis by Type
4.1 Global Gene Therapy Products Sales Market Share by Type (2016-2021)
4.2 Global Gene Therapy Products Revenue Market Share by Type (2016-2021)
4.3 Global Gene Therapy Products Price by Type (2016-2021)

5 Global Gene Therapy Products Historic Market Analysis by Application
5.1 Global Gene Therapy Products Sales Market Share by Application (2016-2021)
5.2 Global Gene Therapy Products Revenue Market Share by Application (2016-2021)
5.3 Global Gene Therapy Products Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Bluebird Bio
6.1.1 Bluebird Bio Corporation Information
6.1.2 Bluebird Bio Description and Business Overview
6.1.3 Bluebird Bio Gene Therapy Products Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Bluebird Bio Gene Therapy Products Product Portfolio
6.1.5 Bluebird Bio Recent Developments/Updates
6.2 Sangamo
6.2.1 Sangamo Corporation Information
6.2.2 Sangamo Description and Business Overview
6.2.3 Sangamo Gene Therapy Products Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Sangamo Gene Therapy Products Product Portfolio
6.2.5 Sangamo Recent Developments/Updates
6.3 Spark Therapeutics
6.3.1 Spark Therapeutics Corporation Information
6.3.2 Spark Therapeutics Description and Business Overview
6.3.3 Spark Therapeutics Gene Therapy Products Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Spark Therapeutics Gene Therapy Products Product Portfolio
6.3.5 Spark Therapeutics Recent Developments/Updates
6.4 Dimension Therapeutics
6.4.1 Dimension Therapeutics Corporation Information
6.4.2 Dimension Therapeutics Description and Business Overview
6.4.3 Dimension Therapeutics Gene Therapy Products Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Dimension Therapeutics Gene Therapy Products Product Portfolio
6.4.5 Dimension Therapeutics Recent Developments/Updates
6.5 Avalanche Bio
6.5.1 Avalanche Bio Corporation Information
6.5.2 Avalanche Bio Description and Business Overview
6.5.3 Avalanche Bio Gene Therapy Products Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Avalanche Bio Gene Therapy Products Product Portfolio
6.5.5 Avalanche Bio Recent Developments/Updates
6.6 Celladon
6.6.1 Celladon Corporation Information
6.6.2 Celladon Description and Business Overview
6.6.3 Celladon Gene Therapy Products Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Celladon Gene Therapy Products Product Portfolio
6.6.5 Celladon Recent Developments/Updates
6.7 Vical Inc.
6.6.1 Vical Inc. Corporation Information
6.6.2 Vical Inc. Description and Business Overview
6.6.3 Vical Inc. Gene Therapy Products Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Vical Inc. Gene Therapy Products Product Portfolio
6.7.5 Vical Inc. Recent Developments/Updates
6.8 Advantagene
6.8.1 Advantagene Corporation Information
6.8.2 Advantagene Description and Business Overview
6.8.3 Advantagene Gene Therapy Products Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Advantagene Gene Therapy Products Product Portfolio
6.8.5 Advantagene Recent Developments/Updates

7 Gene Therapy Products Manufacturing Cost Analysis
7.1 Gene Therapy Products Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Gene Therapy Products
7.4 Gene Therapy Products Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Gene Therapy Products Distributors List
8.3 Gene Therapy Products Customers

9 Gene Therapy Products Market Dynamics
9.1 Gene Therapy Products Industry Trends
9.2 Gene Therapy Products Growth Drivers
9.3 Gene Therapy Products Market Challenges
9.4 Gene Therapy Products Market Restraints

10 Global Market Forecast
10.1 Gene Therapy Products Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Gene Therapy Products by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Gene Therapy Products by Type (2022-2027)
10.2 Gene Therapy Products Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Gene Therapy Products by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Gene Therapy Products by Application (2022-2027)
10.3 Gene Therapy Products Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Gene Therapy Products by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Gene Therapy Products by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Gene Therapy Products Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Gene Therapy Products Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Gene Therapy Products Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Gene Therapy Products Covered in This Study
Table 5. Global Gene Therapy Products Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Gene Therapy Products Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Gene Therapy Products Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Gene Therapy Products Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Gene Therapy Products Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Gene Therapy Products Manufacturing Sites and Area Served
Table 11. Manufacturers Gene Therapy Products Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Gene Therapy Products by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy Products as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Gene Therapy Products Sales by Region (2016-2021) & (K Units)
Table 16. Global Gene Therapy Products Sales Market Share by Region (2016-2021)
Table 17. Global Gene Therapy Products Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Gene Therapy Products Sales by Country (2016-2021) & (K Units)
Table 19. North America Gene Therapy Products Sales Market Share by Country (2016-2021)
Table 20. North America Gene Therapy Products Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Gene Therapy Products Revenue Market Share by Country (2016-2021)
Table 22. Europe Gene Therapy Products Sales by Country (2016-2021) & (K Units)
Table 23. Europe Gene Therapy Products Sales Market Share by Country (2016-2021)
Table 24. Europe Gene Therapy Products Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Gene Therapy Products Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Gene Therapy Products Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Gene Therapy Products Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Gene Therapy Products Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Gene Therapy Products Revenue Market Share by Region (2016-2021)
Table 30. Latin America Gene Therapy Products Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Gene Therapy Products Sales Market Share by Country (2016-2021)
Table 32. Latin America Gene Therapy Products Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Gene Therapy Products Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Gene Therapy Products Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Gene Therapy Products Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Gene Therapy Products Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Gene Therapy Products Revenue Market Share by Country (2016-2021)
Table 38. Global Gene Therapy Products Sales (K Units) by Type (2016-2021)
Table 39. Global Gene Therapy Products Sales Market Share by Type (2016-2021)
Table 40. Global Gene Therapy Products Revenue (Million US$) by Type (2016-2021)
Table 41. Global Gene Therapy Products Revenue Share by Type (2016-2021)
Table 42. Global Gene Therapy Products Price (US$/Unit) by Type (2016-2021)
Table 43. Global Gene Therapy Products Sales (K Units) by Application (2016-2021)
Table 44. Global Gene Therapy Products Sales Market Share by Application (2016-2021)
Table 45. Global Gene Therapy Products Revenue (Million US$) by Application (2016-2021)
Table 46. Global Gene Therapy Products Revenue Share by Application (2016-2021)
Table 47. Global Gene Therapy Products Price (US$/Unit) by Application (2016-2021)
Table 48. Bluebird Bio Corporation Information
Table 49. Bluebird Bio Description and Business Overview
Table 50. Bluebird Bio Gene Therapy Products Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Bluebird Bio Gene Therapy Products Product
Table 52. Bluebird Bio Recent Developments/Updates
Table 53. Sangamo Corporation Information
Table 54. Sangamo Description and Business Overview
Table 55. Sangamo Gene Therapy Products Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Sangamo Gene Therapy Products Product
Table 57. Sangamo Recent Developments/Updates
Table 58. Spark Therapeutics Corporation Information
Table 59. Spark Therapeutics Description and Business Overview
Table 60. Spark Therapeutics Gene Therapy Products Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Spark Therapeutics Gene Therapy Products Product
Table 62. Spark Therapeutics Recent Developments/Updates
Table 63. Dimension Therapeutics Corporation Information
Table 64. Dimension Therapeutics Description and Business Overview
Table 65. Dimension Therapeutics Gene Therapy Products Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Dimension Therapeutics Gene Therapy Products Product
Table 67. Dimension Therapeutics Recent Developments/Updates
Table 68. Avalanche Bio Corporation Information
Table 69. Avalanche Bio Description and Business Overview
Table 70. Avalanche Bio Gene Therapy Products Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Avalanche Bio Gene Therapy Products Product
Table 72. Avalanche Bio Recent Developments/Updates
Table 73. Celladon Corporation Information
Table 74. Celladon Description and Business Overview
Table 75. Celladon Gene Therapy Products Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Celladon Gene Therapy Products Product
Table 77. Celladon Recent Developments/Updates
Table 78. Vical Inc. Corporation Information
Table 79. Vical Inc. Description and Business Overview
Table 80. Vical Inc. Gene Therapy Products Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Vical Inc. Gene Therapy Products Product
Table 82. Vical Inc. Recent Developments/Updates
Table 83. Advantagene Corporation Information
Table 84. Advantagene Description and Business Overview
Table 85. Advantagene Gene Therapy Products Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Advantagene Gene Therapy Products Product
Table 87. Advantagene Recent Developments/Updates
Table 88. Production Base and Market Concentration Rate of Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. Gene Therapy Products Distributors List
Table 91. Gene Therapy Products Customers List
Table 92. Gene Therapy Products Market Trends
Table 93. Gene Therapy Products Growth Drivers
Table 94. Gene Therapy Products Market Challenges
Table 95. Gene Therapy Products Market Restraints
Table 96. Global Gene Therapy Products Sales Forecast by Type (2022-2027) & (K Units)
Table 97. Global Gene Therapy Products Sales Market Share Forecast by Type (2022-2027)
Table 98. Global Gene Therapy Products Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 99. Global Gene Therapy Products Revenue Market Share Forecast by Type (2022-2027)
Table 100. Global Gene Therapy Products Sales Forecast by Application (2022-2027) & (K Units)
Table 101. Global Gene Therapy Products Sales Market Share Forecast by Application (2022-2027)
Table 102. Global Gene Therapy Products Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 103. Global Gene Therapy Products Revenue Market Share Forecast by Application (2022-2027)
Table 104. Global Gene Therapy Products Sales Forecast by Region (2022-2027) & (K Units)
Table 105. Global Gene Therapy Products Sales Market Share Forecast by Region (2022-2027)
Table 106. Global Gene Therapy Products Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 107. Global Gene Therapy Products Revenue Market Share Forecast by Region (2022-2027)
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Gene Therapy Products
Figure 2. Global Gene Therapy Products Market Share by Type in 2020 & 2027
Figure 3. Ex vivo Product Picture
Figure 4. In Vivo Product Picture
Figure 5. Global Gene Therapy Products Market Share by Application in 2020 & 2027
Figure 6. Cancer
Figure 7. Monogenic
Figure 8. Infectious disease
Figure 9. Cardiovascular disease
Figure 10. Other
Figure 11. Global Gene Therapy Products Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Gene Therapy Products Market Size 2016-2027 (US$ Million)
Figure 13. Global Gene Therapy Products Sales 2016-2027 (K Units)
Figure 14. Global Gene Therapy Products Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Gene Therapy Products Sales Share by Manufacturers in 2020
Figure 16. Global Gene Therapy Products Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Gene Therapy Products Players: Market Share by Revenue in 2020
Figure 18. Gene Therapy Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Gene Therapy Products Sales Market Share by Region (2016-2021)
Figure 20. Global Gene Therapy Products Sales Market Share by Region in 2020
Figure 21. Global Gene Therapy Products Revenue Market Share by Region (2016-2021)
Figure 22. Global Gene Therapy Products Revenue Market Share by Region in 2020
Figure 23. U.S. Gene Therapy Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Gene Therapy Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Gene Therapy Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Gene Therapy Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Gene Therapy Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Gene Therapy Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Gene Therapy Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Gene Therapy Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Gene Therapy Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Gene Therapy Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Gene Therapy Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Gene Therapy Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Gene Therapy Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Gene Therapy Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Gene Therapy Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Gene Therapy Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Philippines Gene Therapy Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Vietnam Gene Therapy Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Gene Therapy Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Gene Therapy Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Gene Therapy Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Gene Therapy Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Gene Therapy Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. UAE Gene Therapy Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Gene Therapy Products by Type (2016-2021)
Figure 48. Sales Market Share of Gene Therapy Products by Application (2016-2021)
Figure 49. Sales Market Share of Gene Therapy Products by Application in 2020
Figure 50. Revenue Share of Gene Therapy Products by Application (2016-2021)
Figure 51. Revenue Share of Gene Therapy Products by Application in 2020
Figure 52. Manufacturing Cost Structure of Gene Therapy Products
Figure 53. Manufacturing Process Analysis of Gene Therapy Products
Figure 54. Gene Therapy Products Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed